Nevertheless, the PPV can be fairly low (4.41%) 25 and limitations the screening inhabitants size due to the reliance on experienced otorhinolaryngologists for verification. (EAs)
Structure-Based Design of mTORC1 Inhibitors in Cancer Therapy
mTORC1 inhibitor